EME - 16/126/26

STAR-MS: Autologous Stem Cell Transplantation versus Alemtuzumab or Ocrelizumab in Relapsing Remitting Multiple Sclerosis

Project title: STAR-MS: Autologous Stem Cell Transplantation versus Alemtuzumab or Ocrelizumab in Relapsing Remitting Multiple Sclerosis

Call to action: 16/126 16/126 EME Researcher Led

Research type: Primary Research

Chief investigator: Professor John Snowden

Contractor: Sheffield Teaching Hospitals NHS Foundation Trust

Cost: £2,348,027.54

Co-investigators: Dr Andy Peniket, Dr Eli Silber, Dr Majid Kazmi, Dr Thushan De Silva, Mrs Colette Beecher, Ms Diana Papaioannou, Professor Alasdair Coles, Professor Annalena Venneri, Professor Basil Sharrack, Professor Carolyn Young, Professor Gavin Giovannoni, Professor Neil Scolding, Professor Olga Ciccarelli, Professor Paolo Muraro, Professor Richard Nicholas, Professor Stephen Walters.

Started: January 2019 | Status: Research in progress

ISRCTN: 88667898

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.